$ARIA News Six stocks to watch 3:27 p.m. Feb. 26, 2014

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 10:17 AM

$ARIA News

Six stocks to watch 3:27 p.m. Feb. 26, 2014 - The Trading Deck
6 stocks to watch 3:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 9:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 3:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 1:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 3:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 4:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 3:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 6:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 3:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com

'Fast Money' Recap: Should You Buy European or U.S. Stocks? 5:00 a.m. Today - TheStreet.com
Can Radius Health (RDUS) Surprise This Earnings Season? - Analyst Blog 10:06 a.m. Feb. 13, 2015 - Zacks.com
Hottest Healthcare Stocks Now – GSK ARIA CNMD SLXP 5:30 a.m. Feb. 13, 2015 - InvestorPlace.com
Will Immune Design (IMDZ) Miss on Earnings This Season? - Analyst Blog 2:40 p.m. Feb. 10, 2015 - Zacks.com
Will Ligand Pharmaceuticals (LGND) Miss on Earnings in Q4? - Analyst Blog 9:54 a.m. Feb. 6, 2015 - Zacks.com
Will Pacific Biosciences (PACB) Surprise on Earnings in Q4? - Analyst Blog 4:40 p.m. Feb. 2, 2015 - Zacks.com
Will GW Pharmaceuticals (GWPH) Miss this Earnings Season? - Analyst Blog 2:40 p.m. Feb. 2, 2015 - Zacks.com
3 Biotechs Looking Good this Earnings Season - Earnings ESP 12:38 p.m. Jan. 30, 2015 - Zacks.com
ARIAD: The Worst May Not Be Over 11:15 a.m. Jan. 28, 2015 - Seeking Alpha
ARIAD Pharmaceuticals (ARIA) Flagged As Strong On High Volume 10:01 a.m. Jan. 28, 2015 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – ABMD ARIA WOOF MNKD 5:45 a.m. Jan. 28, 2015 - InvestorPlace.com
InsiderInsights.com Daily Round Up 1/26/15: THRM, FXCM, OPK, TCBI 4:00 a.m. Jan. 28, 2015 - Seeking Alpha
10 Biotechnology Stocks to Sell Now 3:45 a.m. Jan. 28, 2015 - InvestorPlace.com
Earnings Peek: ARIAD Should Easily Beat Outdated Estimates 2:19 p.m. Jan. 27, 2015 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – ARIA MYGN NVS MNKD 5:30 a.m. Jan. 27, 2015 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – LCI HCA MNKD INCY 5:45 a.m. Jan. 26, 2015 - InvestorPlace.com
Seeking Alpha's Biotech Weekly: Salix Sale Murmurs, A Very Active CHMP, And More 4:00 p.m. Jan. 23, 2015 - Seeking Alpha
ARIAD's Iclusig Endorsed by EC for All Approved Indications - Analyst Blog 2:00 p.m. Jan. 21, 2015 - Zacks.com
ARIAD Pharmaceuticals: Is The Ship Turning Around? 11:07 a.m. Jan. 21, 2015 - Seeking Alpha
Hottest Healthcare Stocks Now – NVO CLDX ZLTQ ARIA 5:15 a.m. Jan. 20, 2015 - InvestorPlace.com

What's New in the Pharma Sector: New Research on Amgen, Applied Genetic Technologies, Aptose, ARIAD, and Atara Biotherapeutics 7:40 a.m. Feb. 13, 2015 - PR Newswire - PRF
ARIAD to Present at the RBC Capital Markets’ Healthcare Conference 7:35 a.m. Feb. 11, 2015 - BusinessWire - BZX
Critical Alerts For LinkedIn, Ariad Pharmaceuticals, Tableau Software, Nu Skin Enterprises and CBS Released By InvestorsObserver 9:31 a.m. Feb. 6, 2015 - PR Newswire - PRF
Biotech Stocks Scanner - ARIAD Pharma, Celgene, CytRx, Amicus Therapeutics, and United Therapeutics 9:00 a.m. Feb. 4, 2015 - PR Newswire - PRF
ARIAD to Present at the Leerink Global Healthcare Conference 7:35 a.m. Feb. 3, 2015 - BusinessWire - BZX
ARIAD to Webcast Conference Call on Fourth Quarter and Year-End 2014 Financial Results 7:35 a.m. Jan. 29, 2015 - BusinessWire - BZX
Insider Trading Alerts for FXCM, Achillion Pharmaceuticals, Ariad Pharmaceuticals, Kinder Morgan, Twitter, and Yahoo 8:45 a.m. Jan. 27, 2015 - PR Newswire - PRF
Insider Trading Research for Delta Air Lines, Ariad Pharmaceuticals, Alcoa, Avon, FXCM, and Apple 8:45 a.m. Jan. 23, 2015 - PR Newswire - PRF
ARIAD Announces Appointment of Thomas J. DesRosier, Senior Pharmaceutical-Industry Counsel, as Chief Legal and Administrative Officer 7:35 a.m. Jan. 22, 2015 - BusinessWire - BZX
ARIAD Announces Final Decision from European Commission Endorsing Iclusig’s Approved Indications Throughout Europe 7:35 a.m. Jan. 20, 2015 - BusinessWire - BZX
ARIAD Announces Key Strategic Objectives for 2015 Expected to Lead Company to Profitability in Three Years 7:35 a.m. Jan. 13, 2015 - BusinessWire - BZX
ARIAD Announces Phase 2 Dose-Ranging Trial of Iclusig (Ponatinib) to Begin by Mid-2015 7:35 a.m. Jan. 6, 2015 - BusinessWire - BZX
Striking Deals on Street: New Research on State Investors, NCI, Ariad, Under Armour and Meadowbrook 9:20 a.m. Dec. 31, 2014 - PR Newswire - PRF
ARIAD Announces Commercialization Agreement for Iclusig in Seven Central and Eastern European Countries 7:35 a.m. Dec. 30, 2014 - BusinessWire - BZX
ARIAD To Present at The 33rd Annual J.P. Morgan Healthcare Conference 7:35 a.m. Dec. 22, 2014 - BusinessWire - BZX
Biotech Stocks Technical Insight -- ARIAD Pharma, Geron, PDL BioPharma, Cytori Therapeutics, and Navidea Biopharma 9:15 a.m. Dec. 18, 2014 - PR Newswire - PRF
ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib from Phase 2 Pace Clinical Trial 7:35 a.m. Dec. 8, 2014 - BusinessWire - BZX
Insider Trading Alerts for Hertz, Ariad Pharmaceuticals, J C Penney, Sirius XM, Apple, and Sunedison 8:45 a.m. Nov. 25, 2014 - PR Newswire - PRF
ARIAD and STA Announce Approval of Iclusig (Ponatinib) in Australia 7:35 a.m. Nov. 24, 2014 - BusinessWire - BZX
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene 9:10 a.m. Nov. 14, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

US Foods Faces Major Strike Threat Over Driver Contracts

Teamsters Prep for Possible Strike Against US Foods You can almost hear the union drums beating as 260 drivers from Teamsters Local 282 in New York gear up for what could be a major confrontation with US Foods. The message is loud and clear: pay us what we're worth, or watch your delivery chain grind to a halt. With unanimous approval to strike, this isn't just a...

PMET Grows Mineral Assets at Shaakichiuwaanaan

Resource Expansion at the Shaakichiuwaanaan Property You ever see a resource report that makes you do a double take? That's the vibe here with PMET's game-changing update on their Shaakichiuwaanaan property in Quebec. They've crunched the numbers at the Helios Caesium Zone and CV4 Pegmatite, and the results? A juicy increase in the grade, scale, and tonnage across three...

GNSS Simulator Market: $425M by 2031, Key Insight

GNSS Simulator Market: Gadgets Meet Growth A market that's been quietly bubbling away on the back burner is about to boil over: The GNSS Simulator Market, pegged at a neat $424.6 million by 2031. Yeah, it might be niche, but those in the know can't get enough of these satellite-signal replicators. Why GNSS Simulators are Crushing It There's a bunch of reasons why GNSS...

EAF Relief Fund Launches After Learjet Disaster

Mobilizing Aid: A Community in Crisis Not every day you wake up to a story that digs into your gut like this one. The folks at the Green Acres Mobile Home Community in Palm Beach County got dealt a raw deal. A Learjet crash shook their world apart on November 1st, leaving nine lives lost on that flight and sending hundreds of residents scrambling from their homes. It's a...

RSPO RT2026 Tackles Indonesian Fires and Export Shifts

Indonesia's Burning Questions There's been a lot of smoke—literally and figuratively—hanging over the palm oil industry in Indonesia this year. At the RSPO's Annual Roundtable on Sustainable Palm Oil (RT2026), attendees didn't shy away from addressing the harsh realities. In a year marked by rampant fires, thanks to the blistering El Niño, the RSPO showcased data...

Staypineapple Backs Vets: A Heartwarming Initiative

When Hotels Stand Up for Heroes Every now and then, you stumble upon a company doing something genuinely good, and Staypineapple's effort this November is one of those rare gems. In honor of Veterans Day, they're opening their checkbook to sling some real support to our nation’s vets and retired first responders. Their chosen cause? The American Humane Society's...

HashKey and AMBR Unite to Push AI Frontiers in Finance

Shaping the Future with AI Integration In the whirlwind of innovation, there's always the ones braving the frontier, pushing the very boundaries of what we deem possible. Today, it's HashKey Capital and AMBR joining forces, marching into uncharted financial territories. This partnership is more than just a signature on a piece of paper; it's a declaration—a commitment...

Verismo's SynKIR-110: Revolutionizing CAR T Therapy?

Clinical Stage Wonders and Bold Claims Here's the lowdown on the latest tale from Verismo Therapeutics, a name that's trying real hard to distinguish itself in the CAR T therapy arena. Grab a coffee, pal, and let's wade through what's cooking at their camp with the SynKIR™-110. Breaking Down the Science Jargon For you folks not knee-deep in immunotherapy, let me spell...

Silvercorp Updates El Domo Budget Amid Challenges

Budget Pains for Silvercorp's El Domo Project Folks, if you thought navigating the stock market was a minefield, try mining these days. Silvercorp Metals Inc. had to bump up its budget for the El Domo project in Ecuador—again. This time by $14.6 million. What's causing this fiscal heartache? Everything from rising diesel prices thanks to Ecuador playing games with...

BD Appoints Bagnato as Peripheral Intervention Head

A New Captain for BD's Peripheral Ship Time to pay attention, folks. Franklin Lakes just sent an interesting ripple through their workforce headlines, announcing Bridget Bagnato taking the reins as Worldwide President of BD's Peripheral Intervention division. Come November 16, this medical tech veteran, who's clocked over 27 years with BD, is set to start steering their...